Vanguard Group’s Niagen Bioscience NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $20.9M | Sell |
3,286,498
-735,152
| -18% | -$5.11M | ﹤0.01% | 2601 |
|
|
2025
Q3 | $37.5M | Buy |
4,021,650
+97,083
| +2% | +$980K | ﹤0.01% | 2294 |
|
|
2025
Q2 | $56.6M | Buy |
3,924,567
+383,904
| +11% | +$3.79M | ﹤0.01% | 2069 |
|
|
2025
Q1 | $24.4M | Buy |
3,540,663
+151,116
| +4% | +$950K | ﹤0.01% | 2418 |
|
|
2024
Q4 | $18M | Sell |
3,389,547
-40,809
| -1% | -$223K | ﹤0.01% | 2635 |
|
|
2024
Q3 | $12.5M | Buy |
3,430,356
+43,931
| +1% | +$138K | ﹤0.01% | 2846 |
|
|
2024
Q2 | $9.24M | Buy |
3,386,425
+338,306
| +11% | +$1.13M | ﹤0.01% | 2980 |
|
|
2024
Q1 | $10.6M | Hold |
3,048,119
| – | – | ﹤0.01% | 2931 |
|
|
2023
Q4 | $4.36M | Buy |
3,048,119
+4,477
| +0.1% | +$6.24K | ﹤0.01% | 3342 |
|
|
2023
Q3 | $4.44M | Hold |
3,043,642
| – | – | ﹤0.01% | 3304 |
|
|
2023
Q2 | $4.78M | Sell |
3,043,642
-84,376
| -3% | -$126K | ﹤0.01% | 3322 |
|
|
2023
Q1 | $4.79M | Buy |
3,128,018
+518,823
| +20% | +$924K | ﹤0.01% | 3322 |
|
|
2022
Q4 | $4.38M | Buy |
2,609,195
+377,898
| +17% | +$599K | ﹤0.01% | 3365 |
|
|
2022
Q3 | $2.74M | Buy |
2,231,297
+48,853
| +2% | +$78.6K | ﹤0.01% | 3615 |
|
|
2022
Q2 | $3.65M | Sell |
2,182,444
-598,993
| -22% | -$1.17M | ﹤0.01% | 3532 |
|
|
2022
Q1 | $6.84M | Buy |
2,781,437
+240,414
| +9% | +$657K | ﹤0.01% | 3361 |
|
|
2021
Q4 | $9.5M | Sell |
2,541,023
-90,550
| -3% | -$489K | ﹤0.01% | 3236 |
|
|
2021
Q3 | $16.5M | Buy |
2,631,573
+22,936
| +0.9% | +$189K | ﹤0.01% | 2968 |
|
|
2021
Q2 | $25.7M | Buy |
2,608,637
+266,299
| +11% | +$2.32M | ﹤0.01% | 2719 |
|
|
2021
Q1 | $21.9M | Sell |
2,342,338
-96,218
| -4% | -$763K | ﹤0.01% | 2737 |
|
|
2020
Q4 | $11.7M | Sell |
2,438,556
-22,929
| -0.9% | -$112K | ﹤0.01% | 2912 |
|
|
2020
Q3 | $9.87M | Buy |
2,461,485
+203,829
| +9% | +$983K | ﹤0.01% | 2803 |
|
|
2020
Q2 | $10.4M | Buy |
2,257,656
+52,290
| +2% | +$234K | ﹤0.01% | 2749 |
|
|
2020
Q1 | $7.19M | Buy |
2,205,366
+116,556
| +6% | +$448K | ﹤0.01% | 2779 |
|
|
2019
Q4 | $9M | Buy |
2,088,810
+200,908
| +11% | +$714K | ﹤0.01% | 2909 |
|
|
2019
Q3 | $7.43M | Buy |
1,887,902
+127,069
| +7% | +$542K | ﹤0.01% | 2979 |
|
|
2019
Q2 | $8.19M | Buy |
1,760,833
+700
| +0% | +$2.99K | ﹤0.01% | 2973 |
|
|
2019
Q1 | $7.38M | Buy |
1,760,133
+165,618
| +10% | +$597K | ﹤0.01% | 2981 |
|
|
2018
Q4 | $5.47M | Buy |
1,594,515
+22,437
| +1% | +$78K | ﹤0.01% | 3051 |
|
|
2018
Q3 | $6.74M | Buy |
1,572,078
+88,125
| +6% | +$379K | ﹤0.01% | 3121 |
|
|
2018
Q2 | $5.5M | Buy |
1,483,953
+242,131
| +19% | +$920K | ﹤0.01% | 3185 |
|
|
2018
Q1 | $5.22M | Buy |
1,241,822
+232,771
| +23% | +$1.22M | ﹤0.01% | 3138 |
|
|
2017
Q4 | $5.93M | Buy |
1,009,051
+30,061
| +3% | +$162K | ﹤0.01% | 3060 |
|
|
2017
Q3 | $4.21M | Buy |
978,990
+85,049
| +10% | +$311K | ﹤0.01% | 3178 |
|
|
2017
Q2 | $3.42M | Sell |
893,941
-91,331
| -9% | -$289K | ﹤0.01% | 3215 |
|
|
2017
Q1 | $2.65M | Buy |
985,272
+39,052
| +4% | +$111K | ﹤0.01% | 3291 |
|
|
2016
Q4 | $3.13M | Buy |
946,220
+9,957
| +1% | +$27.1K | ﹤0.01% | 3208 |
|
|
2016
Q3 | $2.79M | Buy |
936,263
+32,011
| +4% | +$118K | ﹤0.01% | 3267 |
|
|
2016
Q2 | $3.74M | Buy |
+904,252
| New | +$4.28M | ﹤0.01% | 3108 |
|
Other funds holding NAGE
TCM
